Dishman Carbogen Amcis Limited

Equities

DCAL

INE385W01011

Market Closed - NSE India S.E. Other stock markets 04:35:03 13/03/2026 pm IST			5-day change	1st Jan Change
158.95 ^INR	-3.79%		-3.22%	-35.80%

05/02	Dishman Carbogen Amcis Limited, Q3 2026 Earnings Call, Feb 04, 2026
03/02	Dishman Carbogen Amcis Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Transcript : Dishman Carbogen Amcis Limited - Shareholder/Analyst Call

Published on 09/27/2024 at 03:00 pm IST

S&P Capital IQ

Presenter Speech
Dharmesh Desai (Executives)

Good afternoon, I, Dharmesh Desai, GM of Secretarial & Legal. Welcome all the members to the 17th Annual General Meeting of the company which is being held

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Dishman Carbogen Amcis Limited

05/02	Dishman Carbogen Amcis Limited, Q3 2026 Earnings Call, Feb 04, 2026
03/02	Dishman Carbogen Amcis Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
03/02	Dishman Carbogen Amcis Dec-quarter Consol Net Loss After Tax 129.7 Million Rupees	RE
27/12	Dishman Carbogen Amcis Limited Approves Issue of Senior, Secured, Rated, Listed, Transferable, Taxable, Redeemable Non-Convertible Debentures Aggregating Up to INR 500 Million	CI
23/12	Dishman Carbogen Amcis to consider fund raising via NCDs	RE
05/11	Dishman Carbogen Amcis Limited, Q2 2026 Earnings Call, Nov 05, 2025
04/11	Dishman Carbogen Amcis Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
26/25/26	Dishman Carbogen Amcis receives EIR from US FDA indicating inspection closure	RE
13/25/13	Dishman Carbogen Amcis Limited, Q1 2026 Earnings Call, Aug 13, 2025
13/25/13	Dishman Carbogen Amcis Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
27/25/27	Dishman Carbogen Amcis Limited Announces the Demise of Shri Janmejay R. Vyas, Chairman & Non-Executive Director on May 27, 2025	CI
22/25/22	Dishman Carbogen Amcis Limited, Q4 2025 Earnings Call, May 22, 2025
22/25/22	Dishman Carbogen Amcis Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
21/25/21	Dishman Carbogen Amcis Says Subsidiary Awarded Drug Manufacturing License From Chinese NMPA	RE
10/25/10	Dishman Carbogen's Shanghai Unit Gets Drug Manufacturing License	MT